Teradyne supplies the testing behind the AI revolution, with fundamentals accelerating and technicals confirming. x.com 

Aehr Test Systems stands to benefit as testing takes a larger share of expanding semiconductor capex. Teradyne CEO Greg Smith says test's share of semiconductor capex rose from 6.4% in 2025 to 8.1% in the first eight months of 2026, with conditions favorable for prolonged ATE growth. Data-center reliability is pushing testing upstream from systems toward packages and wafers, where Aehr dominates wafer-level burn-in. Aehr lacks a dedicated CPU segment. x.com 

Teradyne's growth is slowing, undercutting the AI-test growth valuation that lifted shares 242% in 2025. Q1 revenue nearly doubled to $1.28 billion and EPS of $2.56 beat the $2.04 estimate, but Q2 guidance of $1.15-1.25 billion is nearly 10% lower at the midpoint, and gross margin falls to 58-59% as one-off gains fade. Merchant GPU test revenue is only about $50 million this year against Advantest's entrenched lead, and about 70% AI exposure with concentrated customers magnifies tariff risk. … Show more

Teradyne gains as AI chips grow more complex and expensive, because finding a faulty component before everything is packaged together becomes more valuable, and more AI chips mean more testing. It has just launched three new test instruments built specifically for AI and data-center chips. x.com 

Aehr Test Systems stands to benefit because testing is a bottleneck to scaling AI chips. Testing demand is about to surge. Investors did not question its price-to-sales ratio at 120, despite the current P/S objection. x.com  x.com 

Teradyne looks less dominant in CPO testing than expected after it acknowledged Advantest's capabilities on its earnings call. Per GF Securities, low TSMC SoIC yields have led the industry to cut 2026 CPO shipment forecasts, and Teradyne enters a 2H26 transition: Q2 guidance implies a 6% sequential drop, 55-60% of 2026 revenue falls in the first half, and it trades at 47x 2026 earnings. GF still sees long-term CPO upside, with 2027 CPO revenue possibly $800M. x.com  x.com 

Camtek's AI inspection orders are now turning into sales as customers expand chip production and need tools to catch defects. Preliminary Q3 revenue of $160m is roughly 20% above Q2, with $179m forecast for Q4. x.com 

Advantest beat because it simply grew at its own historical upcycle pace, which Wall Street underestimated. Revenue came in at ¥367B versus ¥336B consensus and a ¥360B forecast; analysts modeled just 2.3% sequential growth, while Advantest's median in an upcycle is closer to 10%. Earlier reports from Teradyne, TSMC and Disco had already signaled HBM4 pulling tester demand forward; Teradyne memory-test revenue below $170M or an AI mix under 65% would have broken that chain. x.com 

Teradyne's Q2 outlook coming in below its Q1 results is concerning when demand should be sky-high, and if later quarters look the same, its P/E would be too high to justify buying. x.com 

Aehr Test Systems' lead hyperscale customer is expanding production with about $6M of follow-on Sonoma orders for a second-generation AI processor. These are production-capacity orders, not evaluations, and the customer expects the second processor eventually to exceed the volumes of the first, already in high-volume production. Teradyne's new burn-in on Titan HP overlaps only with package-level Sonoma work, not FOX-XP wafer-level burn-in that screens dies before costly CoWoS packaging. x.com